Literature DB >> 23698090

Post-esophagectomy anastomotic leaks. The role of the anastomotic location.

Stefano Cafarotti, Alfredo Cesario, Venanzio Porziella, Giovanni Leuzzi, Maria Letizia Vita, Elisa Meacci, Maria Teresa Congedo, Pierluigi Granone.   

Abstract

OBJECTIVE: Esophageal anastomotic leaks are associated with significant morbidity and mortality. The purpose of this study was to retrospectively assess the role of the anastomotic positioning (thoracic or cervical) on the incindence of the anastomotic leak and its severity.
METHODS: In the period 2002-07, we have performed extended esophagectomy with a curative-intent in 63 patients with esophageal cancer. The clinical outcome of the 46 patients where a cervical anastomosis was performed (Group A) has been compared with that of the 17 with thoracic anastomosis (Group B), in terms of leak incidence, pattern of healing, morbidity, and mortality.
RESULTS: Leaks occurred in 11% patients of the in group A and in 8% of the group B. When the dehiscence has occurred in the cervical region 1/4th of patients died before the 30th post-operative day compared to the 3/5th of those where the leak occurred at the level of the thorax.
CONCLUSIONS: On the basis of our findings we suggest the adopt the cervical anastomosis due to lower mortality rate related when leaks occur.

Entities:  

Mesh:

Year:  2013        PMID: 23698090

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

1.  eComment. Oesophagectomy: Could the anastomotic location be an independent prognostic factor?

Authors:  Stefano Cafarotti; Alfredo Cesario; Venanzio Porziella; Pierluigi Granone
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06

2.  Covered self-expanding stent treatment for anastomotic leakage: outcomes in esophagogastric and esophagojejunal anastomoses.

Authors:  Jens Hoeppner; Birte Kulemann; Garbriel Seifert; Goran Marjanovic; Andreas Fischer; Ulrich Theodor Hopt; Hans-Jürgen Richter-Schrag
Journal:  Surg Endosc       Date:  2014-01-01       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.